Reading path

How to Read a Drug Trial

By the end of this path you will be able to follow a medicine from its earliest testing all the way to approval, and read each stage the way a careful appraiser does. You will know what a protocol fixes in advance, how doses and endpoints are chosen, how benefit and harm are weighed, and what a regulator actually requires before a drug reaches the pharmacy.

The path, step by step

1. 1 From Bench to Bedside in Diabetes: Why So Few Discoveries Reach a Patient

   4 min read

   Begin with the whole map, which shows where a single trial sits in the long path from a laboratory idea to an approved medicine and why most candidates never finish the journey.

2. 2 How a Clinical Trial Protocol Is Designed, Section by Section

   5 min read

   Before judging any result, learn how a trial is planned, because the protocol fixes the questions, the population, and the rules of evidence before a single patient is enrolled.

3. 3 How the Right Dose of a Medicine Is Worked Out

   5 min read

   Early phases exist to answer one deceptively hard question, and this explains how the right dose is worked out before a drug is ever tested for benefit.

4. 4 How and Why a Trial Chooses Its Primary Endpoint

   5 min read

   A trial is only as meaningful as what it decides to measure, so here you learn how a primary endpoint is chosen and why that choice shapes everything that follows.

5. 5 Surrogate Endpoints Versus Outcomes in Diabetes Trials

   6 min read

   This draws the line at the heart of drug appraisal, since a lab marker that stands in for benefit is not the same as living longer or feeling better, and knowing which one a trial measured changes how much to trust it.

6. 6 Efficacy Versus Effectiveness, and Why a Careful Reader Checks Which One Is Being Claimed

   5 min read

   A drug that works under ideal trial conditions can behave differently in everyday care, and this teaches you to check which claim is actually being made.

7. 7 What a Data and Safety Monitoring Board Does, and Why It Watches in the Dark

   5 min read

   Benefit is only half the ledger, so this turns to safety and the independent board that watches accumulating harms while a trial is still running.

8. 8 How Much Evidence Proves a Drug Works? Two Trials, One Trial, or One Plus Confirmatory Evidence

   4 min read

   With design and results in hand, step back to the regulator's question of how many trials, and how much confirmation, it takes before a drug is judged to work.

9. 9 How a Drug Gets Its Label and Its Approved Indication

   5 min read

   Approval is not a blank endorsement, and here you see how trial evidence becomes a specific label and indication that defines exactly who the drug is for.

10. 10 What Pharmacovigilance Does: Watching a Medicine's Safety After Approval

    5 min read

    Close the loop after approval, when rare harms can surface only once large numbers take a drug, and learn how ongoing safety surveillance keeps the evidence honest.

Each step is a full article on the Reading the Evidence blog.

Back to all reading paths